GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » Gross Profit

HLB Panagene Co (XKRX:046210) Gross Profit : ₩8,464 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is HLB Panagene Co Gross Profit?

HLB Panagene Co's gross profit for the three months ended in Jun. 2024 was ₩1,741 Mil. HLB Panagene Co's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was ₩8,464 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. HLB Panagene Co's gross profit for the three months ended in Jun. 2024 was ₩1,741 Mil. HLB Panagene Co's Revenue for the three months ended in Jun. 2024 was ₩2,464 Mil. Therefore, HLB Panagene Co's Gross Margin % for the quarter that ended in Jun. 2024 was 70.68%.

HLB Panagene Co had a gross margin of 70.68% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of HLB Panagene Co was 72.89%. The lowest was 57.67%. And the median was 65.65%.


HLB Panagene Co Gross Profit Historical Data

The historical data trend for HLB Panagene Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Panagene Co Gross Profit Chart

HLB Panagene Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,102.46 10,883.48 10,625.45 9,632.51 8,223.14

HLB Panagene Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,881.50 2,224.39 1,938.33 2,559.91 1,741.42

Competitive Comparison of HLB Panagene Co's Gross Profit

For the Biotechnology subindustry, HLB Panagene Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Panagene Co's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Panagene Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where HLB Panagene Co's Gross Profit falls into.



HLB Panagene Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

HLB Panagene Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=12252.031 - 4028.894
=8,223

HLB Panagene Co's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=2463.637 - 722.221
=1,741

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,464 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

HLB Panagene Co's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=1,741 / 2463.637
=70.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


HLB Panagene Co  (XKRX:046210) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

HLB Panagene Co had a gross margin of 70.68% for the quarter that ended in Jun. 2024 => Durable competitive advantage


HLB Panagene Co Gross Profit Related Terms

Thank you for viewing the detailed overview of HLB Panagene Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Panagene Co Business Description

Traded in Other Exchanges
N/A
Address
54, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34027
HLB Panagene Co Ltd Formerly PANAGENE Inc is a South Korea based company engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips.

HLB Panagene Co Headlines

No Headlines